ARTICLE | Product Development
COVID roundup: Vaccine R&D from Murdoch Children’s, Cobra-Karolinska, Altimmune-Alabama
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
March 31, 2020 12:28 AM UTC
A trio of groups announced progress on COVID-19 vaccines Monday, including an Australian trial enrolling volunteers to receive a repurposed tuberculosis vaccine.
Murdoch Children’s Research Institute said it plans to enroll 4,170 healthcare workers to receive the Bacille Calmette-Guérin (BCG) tuberculosis vaccine as part of its BRACE trial. The goal is to determine whether BCG vaccination protects against COVID-19 or reduces disease severity, and whether it could be used as an early intervention to protect healthcare workers and other high-risk groups during future novel viral outbreaks...